Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-010478

CHIEF COMMERCIAL OFFICER gave up 727 shares (to pay taxes)

  • CHIEF COMMERCIAL OFFICER acquired 2,477 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Moat Ross CHIEF COMMERCIAL OFFICER 2025-04-07 Option exercise +2,477 28,401 D
Moat Ross CHIEF COMMERCIAL OFFICER 2025-04-07 Shares withheld for taxes −727 $20.28 $14,744 27,674 D
Derivatives
Moat Ross CHIEF COMMERCIAL OFFICER 2025-04-07 Option exercise · Restricted Share Unit −2,477 2,477 D
Loading xslF345X05/form4-04092025_080436.xml…